| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| Hemosol Inc. |
| Toronto, Canada |
| Business Description | The company primarily develops blood substitutes derived from human hemoglobin. |
|
Filing Information Not yet | |||
| To Trade As | - - (NASNTL) | Industry | Pharmaceutical (SIC 2834) |
| Type of Stock Offered | Common Shares | Filing Date | 1/17/2001 |
| Domestic Shares Filed | 7,000,000 | Filing Price | - - |
| Foreign Shares Filed | 0 | Offering Amount | $0 |
| Company Shares | 7,000,000 | Est. Expenses | - - |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| UBS Warburg LLC | Lead Manager | |
| Dain Rauscher Wessels | Co-manager | (612) 371-2818 |
| Use Of Proceeds |
The proceeds from the proposed offering will be used for general corporate purposes. |